10.1523/ENEURO.0198-16.2016 eNeuro 28 HeppnerK
DOI: 10.1073/pnas.94.5.1997 24
2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity
It doesnt contain antimicrobial agents or preservatives
Consistent with our data in PamKO islets, in humans, during an OGTT there was a strong interaction between genotype and time on glucagon concentration ( p = 0.0009)
Chantoux F, Blondeau JP, Francon J